2017-06-07

c-LEcta signs Sales and Distribution Agreement with Cosmo Bio for Japan

Cosmo Bio Co., Ltd. (Cosmo Bio), one of Japan’s leading life science suppliers of research reagents and research instruments, and the German biotechnology specialist c-LEcta GmbH (c-LEcta), announce the signing of a sales and distribution agreement for c-LEcta’s DENARASE®, a high-quality nuclease for the removal of all forms of DNA and RNA in biopharmaceutical processes. Based on this agreement, DENARASE® will now be available through all regular Cosmo Bio sales channels in Japan. The benefits of DENARASE® at a glance:

  • Full compliance with cGMP
  • Animal product free production
  • Endotoxin-free production strain
  • High purity & activity

DENARASE® is a highly active nuclease that is used to quantitatively eliminate interfering host cell DNA and RNA from fermentation batches, e.g. during the production of vaccines and biopharmaceuticals. Therefore, it is the first choice for pharmaceutical manufacturers to optimize their process efficiencies and improve product recovery rates. DENARASE® is manufactured using a patent protected production process based on the recombinant expression in an endotoxin-free Bacillus sp. production host. The manufacturing process is free of products from animal origin and antibiotics and in full compliance with cGMP requirements.